Compare Merck & Co., Inc. (MRK) vs New Era Energy & Digital Inc. Common Stock (NUAI) Price & Performance

Merck & Co., Inc.Trade

New Era Energy & Digital Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Merck & Co., Inc. vs New Era Energy & Digital Inc. Common Stock — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while New Era Energy & Digital Inc. Common Stock trades at $4.7 (market cap $583.45M). The key difference: Merck & Co., Inc. is far larger — about 602.1× New Era Energy & Digital Inc. Common Stock's market cap, and Merck & Co., Inc. pays a 2.39% dividend while New Era Energy & Digital Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and New Era Energy & Digital Inc. Common Stock for 0 Days on average.

	MRK	NUAI
Market Cap	$351.28B	$583.45M
Volume	7,969,665	17,217,412
Sector	Health	Technology
52-Week High	$156.43	$8.06
52-Week Low	$82.49	$2.35
Typical Hold Time	98 Days	0 Days
Enterprise Value	$398.04B	$528.80M
Dividend Yield	2.39%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Merck & Co., Inc.

Merck (MRK) trades at $144.96, up 1.52% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 72.97% gross margin and 28.07% net income margin for 2025, though its P/E ratio of 113.9 indicates high valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting strategic growth initiatives amid competitive pressures.

The outlook is mixed: analyst consensus is bullish with a $158.78 price target, but technical indicators and a high P/E suggest near-term caution. Key risks include integration challenges from acquisitions and macroeconomic headwinds affecting pharmaceutical R&D investment. Revenue growth and pipeline execution remain critical for sustained upside.

New Era Energy & Digital Inc. Common Stock

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRK

18% Buy82% Sell

Avg holding period · 98 Days

NUAI

100% Buy0% Sell

Avg holding period · 0 Days

Top news

Latest headlines on both assets

MRK

Cantor Fitzgerald raises price targets on Eli Lilly, AbbVie, Merck, and Pfizer amid mixed growth outlooks.24/7 Wall Street · 8 hours agoBullish Global DPP-4 inhibitors market to grow to $15.5B by 2032, driven by type 2 diabetes demand and generics expansion.PRNewsWire · 1 day agoNeutral HP, Merck, and Seagate paid dividends on Oct 7, with Merck leading in per-share payout and HP offering the highest yield.24/7 Wall Street · 1 day agoBullish View details →

NUAI

Grabar Law investigates shareholder claims against Aardvark, Coastal Financial, Erasca, and New Era Energy for alleged misconduct.Grabar Law Office · 1 day agoBearish View details →

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

About New Era Energy & Digital Inc. Common Stock

New Era Energy & Digital develops large-scale data centers in energy-rich U.S. markets for AI training and inference workloads. Its Texas Critical Data Centers project in the Permian Basin combines modular deployment with flexible power solutions.